CMS published its 2026 Medicaid Managed Care Final Rule this week, finalizing requirements that will reshape how managed care organizations (MCOs) operate in Medicaid — with significant downstream implications for independent practices heavily reliant on Medicaid payers.
| Requirement | Effective Date |
|---|---|
| Network adequacy standards | October 1, 2026 (state contract updates required) |
| PA data reporting | January 1, 2027 (first quarterly report due April 2027) |
| Continuity of care protections | 60 days after state adoption |
In 2026, approximately 72% of all Medicaid beneficiaries are enrolled in managed care plans. For practices with significant Medicaid volume, the MCO payer tier is often their single largest administrative burden — consuming 2.5x the staff time per claim compared to commercial fee-for-service plans.
Once quarterly PA data reporting begins in 2027, practices should proactively request their MCO’s PA approval rates by service category. This data benchmarks your denial profile against the payer’s own reported averages — creating a compelling foundation for credentialing renegotiations and appeals.
The PA reform movement is producing a two-track system: blanket PA reductions for low-risk services and gold carding programs that reward high-performing providers with PA exemptions on specific procedures. Both Cigna and Humana expanded their gold carding frameworks this week, potentially exempting thousands of independent practices from PA requirements where historical approval rates meet payer thresholds.
| Metric | Value |
|---|---|
| Average staff hours spent on PA per week (medical practice) | 14.9 hours |
| Average cost of one PA submission | $11–$26 |
| Percentage of PAs ultimately approved | 90%+ |
| Gold carding potential savings per practice (annually) | $45,000–$120,000 |
Pull your PA approval data for the last 12 months with Cigna and Humana. If you’re above 90% for Humana or 92% for Cigna, apply for gold carding status proactively. Payers do not notify providers when they qualify — you must apply.
The shift from AI-assisted to AI-autonomous revenue cycle is accelerating faster than most analysts predicted. Agentic AI systems — AI agents that execute end-to-end workflows across multiple systems without human handoff — are now processing millions of claims across early-adopter health systems, and the ROI data reshaping the investment calculus applies to practices of every size.
Unlike traditional AI tools that surface insights for human review, agentic RCM AI operates as a digital workforce: it receives scheduling data, verifies eligibility, flags coverage gaps, and triggers PA requests; it extracts billable codes, scrubs claims, and submits; it receives denial notices, retrieves clinical documentation, drafts appeals, and submits — all without human handoff, operating 24/7 across EHR, PM, clearinghouse, and payer portals.
| Vendor | Metric | Result |
|---|---|---|
| Thoughtful AI (Sofia Agent) | Monthly claims processed autonomously | 1.2M+ |
| Thoughtful AI | Denial rate for autonomously processed claims | 4.2% (vs. 8–12% industry) |
| AKASA | Cost per claim processed | $2.10 (vs. $5–$8 manually) |
| AKASA | FTE equivalent productivity ratio | 1 agent = 14 billing staff |
| Cohere Health | Prior auth approvals completed autonomously | 78% |
| Notable Health | Patient intake-to-eligibility automation rate | 94% |
The question is no longer whether to adopt agentic AI — it’s which workflow to automate first. The sequence delivering fastest ROI: (1) eligibility verification, (2) claim scrubbing and submission, (3) denial routing and appeal drafting. Eligibility is the highest-volume, lowest-risk starting point.
Two significant coding developments demand immediate attention from practices across specialties this week.
The AMA released updated guidance clarifying the documentation requirements for split/shared E/M visits — a longstanding gray area driving widespread payer audits and overpayment demands. Key clarifications:
A new analysis estimates that independent physician groups collectively miss $2.8 billion in legitimate HCC risk adjustment revenue annually from incomplete documentation of HCC diagnoses at annual wellness visits, failure to document chronic conditions at every relevant encounter, and insufficient coding specificity.
| Condition | HCC Category | Common Documentation Gap |
|---|---|---|
| Diabetes with complications | High weight (0.302–0.405) | “Diabetes” documented without specifying complications |
| CHF with ejection fraction | High weight (0.368) | CHF coded without specifying EF status |
| COPD severity | High weight (0.335) | COPD coded without severity classification |
| Chronic kidney disease | High weight (0.289–0.538) | CKD stage not specified |
| Major depression, recurrent | High weight (0.310) | “Depression” coded without specifying recurrence |
For practices with Medicare Advantage patients, HCC accuracy is direct revenue. A practice with just 200 MA patients that improves HCC capture by 15% can recover $80,000–$150,000 in annual premium revenue without seeing a single additional patient.
Days in A/R gets the headlines, but First-Pass Resolution Rate (FPRR) — the percentage of claims paid correctly on first submission without denial, rejection, or re-submission — may be the single highest-leverage metric in your revenue cycle. The gap between industry average and top performers is dramatic, and it compounds silently month over month.
Every denied claim costs you twice: the original revenue delay and the administrative cost of rework. MGMA estimates the cost to rework a denied claim at $25–$118 depending on complexity — and that’s before accounting for the time value of delayed payment or the 15–30% of reworked claims that end up written off regardless.
| Category | First-Pass Resolution Rate | Annual Revenue Impact |
|---|---|---|
| Bottom quartile | < 78% | $350K–$800K lost in rework + write-offs |
| Industry average | 84% | — |
| Target | > 92% | — |
| Top performers | 95%+ | — |
For a $3M annual billing practice at 84% FPRR, improving to 85% translates to approximately $30,000 in annual revenue recovery. Improving from 84% to 92% is worth $240,000+ — more than most independent practices spend on their entire billing operation annually.
Pull your FPRR from your PM system this week. If you can’t access this metric, that itself is the first problem — you need visibility before you can manage it. Ask your billing team or vendor for last 90 days of first-pass vs. rework claim volume.
An arms race is underway in claims adjudication that will define RCM operations for the next decade. Payers are deploying increasingly sophisticated AI systems to review and deny claims faster than human reviewers ever could, and providers are responding with dedicated counter-AI platforms designed specifically to fight back — and winning at a higher rate than most practices realize is possible.
| Denial Type | % AI-Generated | Overturn Rate on Appeal |
|---|---|---|
| Medical necessity | 67% | 71% |
| Clinical validation | 58% | 68% |
| Level of care | 72% | 74% |
| Coding accuracy | 41% | 53% |
| Duplicate claim | 89% | 92% |
Vendors have emerged specifically to fight payer AI with provider AI: Overturn.ai detects AI-generated denials and routes them to automated appeal workflows with a 78% overturn success rate; XiFin launched AI-powered underpayment detection covering 2,400+ payer contracts; Experian Health Claims Scrubber 2.0 now flags claims with >15% denial probability before submission.
The era of reactive denial management is ending. The new paradigm is predictive prevention: using AI to identify and fix claim vulnerabilities before submission, so payer AI never has a valid reason to deny. Practices still in purely reactive mode are fighting a losing battle with last decade’s tools.
The HHS Office of Inspector General’s 2026 Work Plan is now in its active audit phase, with OIG investigators requesting records from providers across the country. Several high-risk billing areas are directly relevant to independent practices and should be prioritized for immediate self-audit. OIG audit demands generate overpayment repayment demands with interest.
CMS extended many telehealth flexibilities through end of 2026, but OIG is actively reviewing billing under post-PHE standards: audio-only telehealth billed at higher E/M levels than documentation supports; telehealth visits for services requiring in-person components; missing required telehealth billing modifiers (95, GT) on claims.
OIG is reviewing medical decision-making documentation under the 2021 E/M guidelines: MDM complexity coded at higher level than documented diagnoses/data/risk support; billing 99214/99215 for encounters where documentation supports 99213; inadequate documentation of social determinants when used to elevate MDM complexity.
OIG is expanding oversight of MA plan PA denials that conflict with Medicare coverage criteria — aligned with the CMS-0062-P proposed rule. Providers can submit OIG tips documenting payer medical necessity denial patterns.
| Target Area | 2026 Recovery Goal |
|---|---|
| Telehealth overpayments | $1.2B |
| E/M overpayments | $840M |
| MA improper payments | $2.1B |
An OIG audit demand is a financial event, not a clinical one. Practices with significant Medicare/MA volume should self-audit their top 5 billed procedures and E/M level distribution against MGMA specialty benchmarks. If your profile skews significantly higher than peers, investigate proactively — before OIG does.
The MGMA 2026 Physician Compensation and Production Report — released this week — reveals a persistent compensation gap between independent and employed physicians, while documenting the operational advantages that high-performing independent practices are leveraging to close the revenue gap.
MGMA identified that independent practices in the top quartile of net collection rate (>96%) have median physician compensation 14% higher than bottom-quartile peers (NCR <90%) — even controlling for specialty and geography. RCM performance is the single largest controllable variable in independent physician income.
| Metric | Struggling Practices | Thriving Practices |
|---|---|---|
| Net Collection Rate | < 90% | > 96% |
| Days in A/R | > 45 days | < 30 days |
| Staff cost as % of revenue | > 38% | < 28% |
| Denial rate | > 12% | < 5% |
| Technology spend as % of revenue | < 1.5% | 2.5–3.5% |
The counterintuitive finding: thriving independent practices spend more on technology (as % of revenue) than struggling ones — but dramatically less on staff. The math: a billing tech stack at $80,000/year replacing 2 FTE billing positions at $120,000 combined saves $40,000+ while improving accuracy. RCM technology investment is not a cost center — it’s a margin generator.
| Benchmark | Where Most Are | Where You Should Be |
|---|---|---|
| Net Collection Rate | 91–93% | > 96% |
| Days in A/R | 38–45 days | < 30 days |
| First-Pass Resolution Rate | 80–85% | > 92% |
| Denial Rate | 8–12% | < 5% |
| Cost to Collect | 6–8% | < 4% |
| Technology spend (% of revenue) | 0.8–1.5% | 2–3.5% |
| Billing staff FTE per $1M revenue | 1.8–2.5 | < 1.2 |
Use the MGMA compensation report as a benchmark not just for physician pay, but for the RCM metrics that drive it. If your net collection rate is below 93%, calculate what a 3-point improvement would mean in physician take-home — for most practices, it’s $20,000–$60,000 per physician per year.
| Specialty | Key Update | Impact |
|---|---|---|
| Neurology | CMS published preliminary 2027 coverage policy guidance for transcranial magnetic stimulation (TMS) expansion to include depression + anxiety comorbidities. PA requirements remain, but new LCD guidance clarifies documentation standards. Neurology practices currently report a 32% denial rate for TMS claims due to documentation ambiguity under existing coverage policy. | Update TMS documentation templates to match new LCD criteria now — before payers update their denial engines. The 32% TMS denial rate is largely addressable through proactive documentation improvement. |
| Gastroenterology | CMS confirmed colorectal cancer screening colonoscopy for Medicare beneficiaries remains 100% covered with no cost-sharing. However, coding for polyp removal during a screening colonoscopy remains a high-error area — modifier usage errors account for 23% of GI denials nationally. | Train coders on the 45378/45380 modifier decision tree. A single polyp removal changes cost-sharing status and requires precise modifier assignment. This is high-volume, high-error-rate with a clear technical fix. |
| Oncology | The comment period for CMS-0062-P (Drug PA Reform) closes June 15. Oncology has the most to gain from the proposed 24-hour urgent drug PA window — chemotherapy PA delays average 5.4 days under current payer timelines. ASCO has organized a member comment campaign. | Submit your practice’s specific drug PA delay data to CMS via regulations.gov before June 15. Quantify delays in days and document patient care impacts. This is one of the most consequential comment periods for oncology billing in years. |
| Primary Care | HRSA released the 2026 Health Professional Shortage Area (HPSA) designations — practices in HPSA areas are eligible for 10% Medicare bonus payments on all Part B services. 2,400 new HPSA designations were added in 2026. | Verify your HPSA status at hrsa.gov. If you qualify, confirm modifier QB or QU is applied to all Medicare claims. This is automatic money most practices miss — worth $15,000–$40,000 per physician annually. |
| Orthopedics | Bundled payment programs for joint replacement (successor to the CJR model) are being piloted in 30 metropolitan markets. Practices in pilot markets must now track total episode cost, not just surgical billing. Ancillary spend (PT, imaging, DME) flows back to the practice’s quality and cost score. | If your market is in a pilot zone, establish an episode cost tracking dashboard before CMS begins sending performance data in Q3 2026. Understanding your cost profile proactively prevents surprise reconciliation demands. |
HPSA bonus payments are among the most consistently missed revenue opportunities in primary care. A 10% bonus on Medicare Part B services adds $15,000–$40,000 per physician annually with zero additional work required beyond correct modifier application. Check your status at hrsa.gov/shortage-areas today.